ERK signaling also seems to participate in the acquisition of stemness features in osteosarcoma (expression of CD24, CD90, CD133, Nanog, SOX2, Oct4) mediated by miR-155; moreover, ERK inhibition with U0126 repressed expression of those markers [123]. Here, NANOG is linked to osteosarcoma.